Home > Cashflow Statement > BIOCON

BIOCON
Cashflow Statement

BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹1,525 Cr₹897 Cr₹983 Cr₹1,068 Cr₹1,186 Cr
Adjustment ₹2,356 Cr₹1,685 Cr₹1,245 Cr₹710 Cr₹606 Cr
Changes In working Capital ₹-635 Cr₹-501 Cr₹-790 Cr₹-424 Cr₹-165 Cr
Cash Flow after changes in Working Capital ₹3,246 Cr₹2,081 Cr₹1,439 Cr₹1,354 Cr₹1,627 Cr
Cash Flow from Operating Activities ₹2,954 Cr₹1,853 Cr₹1,177 Cr₹1,160 Cr₹1,283 Cr
Cash Flow from Investing Activities ₹-1,005 Cr₹-14,282 Cr₹-1,699 Cr₹-3,625 Cr₹-1,559 Cr
Cash Flow from Financing Activities ₹-2,333 Cr₹13,049 Cr₹242 Cr₹2,564 Cr₹388 Cr
Net Cash Inflow / Outflow ₹-383 Cr₹619 Cr₹-280 Cr₹99 Cr₹112 Cr
Opening Cash & Cash Equivalents ₹1,300 Cr₹654 Cr₹897 Cr₹825 Cr₹659 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger --₹34 Cr₹-34 Cr-
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹2.90 Cr₹22 Cr₹3.30 Cr₹7.10 Cr₹54 Cr
Closing Cash & Cash Equivalent ₹920 Cr₹1,295 Cr₹654 Cr₹897 Cr₹825 Cr

Compare Cashflow Statement of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹41,396.7 Cr -0.9% 2.5% 35.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,103.0 Cr 1% 0.7% 47.3% Stock Analytics
DIVIS LABORATORIES ₹153,540.0 Cr -1.1% -5.8% 61.7% Stock Analytics
CIPLA ₹119,196.0 Cr 0.3% -1.8% 19.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,752.0 Cr 6% 11.8% 20.3% Stock Analytics
ZYDUS LIFESCIENCES ₹97,041.2 Cr -1.5% -0.1% 47% Stock Analytics


BIOCON Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-0.9%

2.5%

35.9%

SENSEX

-2.7%

-0.8%

9.9%


You may also like the below Video Courses